WeVote
Log In

Bill

Bill

HB 422

AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO ENHANCED INFORMED CONSENT FOR INFANT VACCINATIONS AND DOCUMENTATION IN SUDDEN UNEXPECTED INFANT DEATH INVESTIGATIONS.

153rd General Assembly (2025-2026) Introduced by Jeff Hilovsky and 6 co-sponsors

HB 422 would require more thorough informed consent for infant vaccines and standardize SUIDI documentation, affecting providers, families, and investigators.

Adopted in lieu of the original bill HB 422, and Assigned to Health & Human Development Committee in House
0
WeVote Research Nonpartisan
Bill Summary · HB 422

Overview

HB 422 (Session 153, Delaware) seeks to amend Title 16 of the Delaware Code to establish enhanced informed consent requirements for infant vaccinations and to modify documentation in relation to Sudden Unexpected Infant Death Investigations (SUIDI). The bill was introduced May 14, 2026, and assigned to the Health & Human Development Committee in the House. It has a broad sponsor group, including six co-sponsors.

Main purpose and intent

  • To strengthen the process of informed consent for infant vaccinations.
  • To address and revise documentation practices specifically connected to Sudden Unexplained Infant Death Investigations (SUIDI), with an emphasis on how information is collected, recorded, and communicated in these cases.
  • The underlying aim appears to be ensuring that parents or guardians receive more detailed information prior to vaccinating infants and that SUIDI-related records reflect enhanced documentation standards.

Key provisions and changes (as described by the bill title and scope)

  • Enhanced informed consent for infant vaccinations:
    • Likely requires more comprehensive information to be provided to parents/guardians before administering vaccines to infants.
    • Could specify content of consent discussions, such as benefits, risks, alternatives, and potential long-term outcomes.
    • May impose particular timing or manner requirements for obtaining consent (e.g., in writing, with specific signatures, or with disclosures to guardians).
  • Documentation in Sudden Unexpected Infant Death Investigations (SUIDI):
    • May establish standardized documentation protocols for investigations into Sudden Unexplained Infant Deaths.
    • Could mandate specific forms, data elements, or reporting timelines to ensure consistency across investigations.
    • Possibly addresses confidentiality, chain of custody, and coordination with medical examiner or coroner processes.

Note: The exact statutory text is not provided here, so the summary reflects the bill’s stated focus on enhanced informed consent for vaccines and documentation related to SUIDI investigations.

Who would be affected

  • Infants receiving vaccines: Enhanced consent processes would directly impact parents/guardians and healthcare providers administering vaccines.
  • Parents/guardians of infants: Required to receive more detailed information prior to vaccination and participate in a more robust informed consent process.
  • Healthcare providers and facilities that administer infant vaccines: Responsible for implementing enhanced consent procedures and ensuring documentation is completed as required.
  • Agencies and professionals involved in SUIDI: Medical examiners, coroners, and investigators, along with health departments, would need to adopt standardized documentation practices for SUIDI cases.
  • Public health and child welfare systems: May experience changes in data collection, reporting, and interagency communication related to vaccination consent and SUIDI documentation.

Procedural and timeline aspects

  • Introduction and assignment: HB 422 was introduced on May 14, 2026, and assigned to the Health & Human Development Committee in the House.
  • Next steps (typical for such bills): Committee review, potential amendments, floor debate and vote in the House, transmission to the Senate (and corresponding committee process), and eventual governor’s consideration.
  • Specific effective dates and transitional provisions: Not provided in the summary. If enacted, the bill would likely include effective dates for phased implementation, as is common with health-related statutory changes.

Potential impacts and considerations

  • Public health/individual choice balance: Enhanced consent could strengthen parental rights and information, while imposing additional requirements on healthcare providers.
  • Administrative burden: Providers and health departments may face increased administrative tasks for consent documentation and SUIDI record-keeping.
  • Privacy and data handling: Tighter documentation for SUIDI may necessitate clear privacy protections and data access controls.
  • Implementation scope: The bill’s impact will depend on the exact language, including whether it applies to all vaccines administered to infants (e.g., within a set age window) and how broadly SUIDI documentation requirements are defined.

Summary

HB 422 aims to tighten informed consent procedures for infant vaccinations and to standardize documentation in Sudden Unexpected Infant Death Investigations. If enacted, it would require more thorough information be provided to parents/guardians before vaccination and establish enhanced documentation practices for SUIDI cases, affecting healthcare providers, families, and investigative agencies. The bill is currently in the early stages of the legislative process, with formal timelines to be clarified through committee action and floor votes.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.